The Foundation of Patients with Hepatitis B and C and Other Immunological Diseases in the Dominican Republic (Funpaheinm) has clarified that treatment against hepatitis B is not currently covered by the Alto Costo program. However, the foundation is calling on the government to include this treatment in the program, as it is essential for the prevention and treatment of the disease.
Hepatitis B is a serious liver disease that can be fatal if left untreated. The disease is caused by the hepatitis B virus (HBV), which is transmitted through blood, semen, and other bodily fluids. There is no cure for hepatitis B, but there are treatments that can help to prevent the disease from progressing and to reduce the risk of complications.
The Alto Costo program is a government program that provides financial assistance to people with chronic diseases that require expensive treatments. The program currently covers treatment for a number of diseases, including hepatitis C, but it does not cover treatment for hepatitis B.
Funpaheinm argues that the government should include treatment for hepatitis B in the Alto Costo program. The foundation points out that hepatitis B is a more common disease than hepatitis C, and that it is also more difficult to treat. Funpaheinm also argues that including treatment for hepatitis B in the Alto Costo program would help to reduce the number of people who die from the disease.
The government has not yet responded to Funpahein’s request. However, the foundation is hopeful that the government will eventually include treatment for hepatitis B in the Alto Costo program.
In addition to the above, here are some other details that could be included in the news post:
- The cost of treatment for hepatitis B can be prohibitive for many people.
- Treatment for hepatitis B can help to prevent the disease from progressing to cirrhosis or liver cancer.
- The Alto Costo program is funded by the government, but it is also supported by private donations.
- Funpaheinm is a non-profit organization that works to improve the lives of people with hepatitis B and C.